Trastuzumab rezetecan

HY-164762
Product group Antibodies
Overview
- SupplierMedChem Express
- Product NameTrastuzumab rezetecan
- Delivery Days Customer9
- CertificationResearch Use Only
- Scientific DescriptionTrastuzumab rezetecan (SHR-A1811) is a HER2-targeting antibody-drug conjugate (ADC). Trastuzumab rezetecan is composed of a humanized anti-HER2 antibody (HY-P9907), a cleavable linker MC-Gly-Gly-Phe-Gly (HY-44246), and a topoisomerase I inhibitor payload Rezetecan (HY-147408). Trastuzumab rezetecan can be used for research in HER2-positive breast cancer[1].
- UNSPSC12352203